MESO FY 2009 Earnings — Mesoblast Limited Revenue & Financial Results | Market Cap Arena

MESOMesoblast Limited

$2B

FY 2009 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$890,708-2.1% YoY

Gross Profit

$890,708100.0% margin

Operating Income

-$9M-1058.6% margin

Net Income

-$12M-1379.3% margin

EPS (Diluted)

$-0.23

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$27M

Total Liabilities

$1M

Stockholders' Equity

$26M

Cash & Equivalents

$17M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$890,708	$909,807	-2.1%
Gross Profit	$890,708	$909,807	-2.1%
Operating Income	-$9M	-$8M	-18.8%
Net Income	-$12M	-$10M	-22.1%